Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To view this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Click here to view
our current issue


Cell Centre

Robust cell line development is seen by many as intensive and time-consuming, but it is key to process optimisation, particularly for recombinant therapeutic antibodies ensuring stable production and lowering product costs

Louis Boon, Bioceros BV (December 2013)

Keywords: Recombinant proteins, Chinese hamster ovary (CHO) cell lines, Metabolic selection, Biosimilar monoclonal antibodies (mAbs), Cost of goods (CoGs)

    View full article    |    Back to Biopharma section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |